- Report
- November 2025
- 471 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 371 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 340 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 462 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 291 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 382 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 370 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 273 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 287 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 373 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 383 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 179 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 478 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 434 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 169 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 170 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 367 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 363 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 167 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more